Abiomed (ABMD) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

ProductService And Other
050M100M150M200M250M300M350M400MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue by Geography

UNITED STATESOutside the U.S MemberEuropeJAPANNon Us Non Europe Non JapanNon Us
050M100M150M200M250M300M350M400MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0100M200M300M400M500M600M700M800MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Operating Expenses

Research And Development ExpensesSelling General And Administrative Expenses
025M50M75M100M125M150M175M200MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

EBITDA

EBITDA
038M75M112M150M188M225M262M300MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

EPS

EPSEPS Diluted
012234456Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue Variation (%)

Revenue Variation
-5-4-2-012467Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue YoY Variation (%)

Revenue YoY Variation
048111519222630Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Price-to-Earning Ratio

P/E Ratio
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
050M100M150M200M250M300M350M400MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
02581012151820Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
038M75M112M150M188M225M262M300MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Cash Flow to Debt Ratio

Cash At End Of Period
038M75M112M150M188M225M262M300MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023
🏦 Balance Sheet
📈 Key Metrics